TY  - GEN
AU  - Deisseroth,A B
AU  - Holmes,F
AU  - Hortobagyi,G
AU  - Champlin,R
TI  - Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial
SN  - 1043-0342
PY  - 1996///1206
KW  - ATP Binding Cassette Transporter, Subfamily B, Member 1
KW  - genetics
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Marrow Diseases
KW  - chemically induced
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Carmustine
KW  - administration & dosage
KW  - Cyclophosphamide
KW  - DNA, Complementary
KW  - DNA, Recombinant
KW  - Defective Viruses
KW  - Drug Resistance, Neoplasm
KW  - Ethics, Medical
KW  - Feasibility Studies
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - pharmacology
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hematopoietic Stem Cells
KW  - drug effects
KW  - Humans
KW  - Interleukin-3
KW  - Interleukin-6
KW  - Mesna
KW  - Middle Aged
KW  - Paclitaxel
KW  - Pilot Projects
KW  - Recombinant Fusion Proteins
KW  - metabolism
KW  - Retroviridae
KW  - Safety
KW  - Thiotepa
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1089/hum.1996.7.3-401
ER  -